SEBI bars Rajesh Exports MD over alleged ₹15.15 lakh cr revenue misstatement; stock hits lower circuit

SEBI passed an interim order barring Rajesh Exports MD Rajesh Mehta from securities dealings, alleging ₹15.15 lakh crore revenue misrepresentation and fund-routing through subsidiary Valcambi. Mehta denied findings; shares hit 5% lower circuit at ₹103.92.